Board approves preferential issue of shares and convertible warrants

Fund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.3%Reaction day

₹374.00

prior close

₹380.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.0%+4.3% vs market

Pharmaceuticals peers, median of 173sector-0.7%+5.0% vs sector

On the reaction day the stock moved 4.3 pts more than Nifty Microcap 250 and 5.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

+0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.3+0.0+4.3-0.7+5.0

Next day

+5.4+1.3+4.1+0.6+4.8

+4.1+1.1+3.0+0.3+3.7

-0.7-1.7+1.0-2.3+1.6

-0.0-1.4+1.4-2.1+2.1

+1.9-0.6+2.5-2.5+4.4

+6.4+0.3+6.1-2.5+9.0

15d

+16.4-6.1+22.5-4.4+20.9

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved preferential allotment of 12,22,200 equity shares at Rs 336.60 each to non-promoter public, worth about Rs 41.14 crore. Also approved up to 5,00,400 fully convertible warrants at Rs 336.60 each to promoter group and others, worth up to Rs 16.84 crore. Total potential raise is around Rs 57.98 crore from 33 allottees. Promoter stake will fall from 62.46 percent to 56.35 percent. EGM scheduled for October 27, 2026 for shareholder approval.

Likely market impact

Equity dilution with promoter stake dropping to about 56 percent. Fund raise of around Rs 58 crore pending shareholder nod on Oct 27.